申请人:BEECHAM GROUP PLC
公开号:EP0089139A2
公开(公告)日:1983-09-21
1. A compound of the formula (II):
or a pharmaceutically acceptable salt or pharmaceutically acceptable ester thereof, wherein R1 is hydrogen, -CHO or -SO3H or a pharmaceutically acceptable salt thereof, R2 is C1-6 alkyl or benzyl, and R3 is an optionally substituted pyrimidinyl group. Processes for the preparation of such compounds and pharmaceutical compositions containing these compounds are also disclosed.
式(II)化合物:或其药学上可接受的盐或药学上可接受的酯,其中R1为氢、-CHO或-SO3H或其药学上可接受的盐;R2为C1-6烷基或苄基;R3为任选取代的嘧啶基。 还公开了制备此类化合物和含有这些化合物的药物组合物的工艺。